Figure 1.
Absolute percentage of patients who developed de novo DSAs by month 84 in (A) BENEFIT and (B) BENEFIT‐EXT. CI, confidence interval; CsA, cyclosporine; DSA, donor‐specific antibody; LI, less intense; MI, more intense
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.